21
Aug 2013This good news is just in from our wonderful “Travellers’ Health Partners” InterHealth: Malarone® is used to prevent and treat malaria and was patented in the UK by GlaxoSmithKline (GSK). Earlier this year the UK Patents Court revoked GSK’s patent for Malarone®. This paved the way for other companies to produce and sell what’s known as a ‘generic’ version of Malarone® in the UK at a lower price than GSK’s branded name, Malarone®.
Generic versions of a drug contain the same active ingredients as the originally patented drug. In the case of Malarone®, this means a combination of atovaquone and proguanil, and it is these two key ingredients which provide the name of the generic version: atovaquone and proguanil. This generic medication is fully licensed in the UK and is used in the same way as Malarone®.
For more information infomration please read this document
Please select the social network you want to share this page with:
We like you too :)
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec tincidunt dapibus dui, necimas condimentum ante auctor vitae. Praesent id magna eget libero consequat mollis.
